Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma

Modern Pathology

Volumn 13, Issue 10, 2000, Pages 1060-1065

  Kato, Masako ^a   Maeta, Hiroyuki ^a   Kato, Shinsuke ^b   Shinozawa, Takao ^c   Terada, Tadashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; In situ hybridization; Midkine; Papillary carcinoma; Thyroid

Indexed keywords

MESSENGER RNA; MIDKINE;

ADULT; AGED; ARTICLE; CANCER INVASION; DNA SEQUENCE; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA; TUMOR CELL;

EID: 0033788812     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880195     Document Type: Article

References (25)

1. cDNA cloning and sequencing of a new gene intensity expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis
2. A retinoic acid-responsive gene, MK, found in the teratocarcinoma
3. Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation
4. Midkine, a retinoic acid-inducible growth/differentiation factor: Immunochemical evidence for the function and distribution
5. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis
6. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis
7. Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis
8. Growth factors and cancer
9. Growth factors in development, transformation, and tumorigenesis
10. A new family of heparin-binding growth/differentiation factors: Increased midkine expression in Wilms' tumor and other human carcinomas
11. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues
12. Midkine and pleiotrophin expression in normal and malignant breast tissue
13. Increased midkine gene expression in human gastrointestinal cancers
14. Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors
15. Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy
16. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
17. Midkine that promotes survival of fetal human neurons is produced by fetal human astrocytes in culture
18. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture
19. Midkine, a novel neurotrophic factor, promotes survival of mesencephalic neurons in culture
20. Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity
21. A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity
22. Autocrine growth factors and cancer
23. Demonstration of a TGF-alpha-EGF receptor autocrine loop and c-myc protein over expression in papillary thyroid carcinomas
24. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers